Biocartis Group NV (BCART.BR)
20 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-Biocartis & Immunexpress Partnership For A Sepsis Host Immune Response Test
- BRIEF-Biocartis And Amgen Sign New Agreement
- BRIEF-Biocartis And Amgen Sign Companion Diagnostic Agreement For Idylla(Tm) RAS Biomarker Tests
- BRIEF-Biocartis Raises 80 Million Dollars
- BRIEF-Bookrunner says Biocartis Group deal upsized to 80 mln euros From 60 mln euros base deal size